171 related articles for article (PubMed ID: 34086013)
21. Stimulated-echo diffusion-weighted imaging with moderate b values for the detection of prostate cancer.
Zhang Y; Wells SA; Triche BL; Kelcz F; Hernando D
Eur Radiol; 2020 Jun; 30(6):3236-3244. PubMed ID: 32064561
[TBL] [Abstract][Full Text] [Related]
22. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
23. T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy.
Sun C; Wang S; Chatterjee A; Medved M; Eggener S; Karczmar GS; Oto A
Eur Radiol; 2021 Jan; 31(1):325-332. PubMed ID: 32785769
[TBL] [Abstract][Full Text] [Related]
24. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
[No Abstract] [Full Text] [Related]
25. Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review.
Al-Khalil S; Boothe D; Durdin T; Sunkara S; Watkins P; Yang S; Haynes A; de Riese W
Int Urol Nephrol; 2016 Jan; 48(1):91-7. PubMed ID: 26590832
[TBL] [Abstract][Full Text] [Related]
26. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI.
Costa DN; Jia L; Subramanian N; Xi Y; Rofsky NM; Recchimuzzi DZ; de Leon AD; Arraj P; Pedrosa I
AJR Am J Roentgenol; 2021 Aug; 217(2):395-403. PubMed ID: 32876473
[No Abstract] [Full Text] [Related]
27. Multispecies comparative prostate anatomy by imaging: Implications for experimental models of prostatic disease.
Berg FM; Correia ETO; Abenojar EC; Basilion JP; Rosol TJ; Baroni RH; Exner AA; Bittencourt LK
Prostate; 2024 May; 84(7):682-693. PubMed ID: 38477025
[TBL] [Abstract][Full Text] [Related]
28. Effect of intravascular contrast agent on diffusion and perfusion fraction coefficients in the peripheral zone and prostate cancer.
Mazaheri Y; Hötker AM; Shukla-Dave A; Akin O; Hricak H
Magn Reson Imaging; 2018 Sep; 51():120-127. PubMed ID: 29678542
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of prostate cancer and benign prostatic hyperplasia: comparisons of the histogram analysis of intravoxel incoherent motion and monoexponential model with in-bore MR-guided biopsy as pathological reference.
Cui Y; Li C; Liu Y; Jiang Y; Yu L; Liu M; Zhang W; Shi K; Zhang C; Zhang J; Chen M
Abdom Radiol (NY); 2020 Oct; 45(10):3265-3277. PubMed ID: 31549212
[TBL] [Abstract][Full Text] [Related]
30. Likelihood of prostate cancer based on prostate-specific antigen density by MRI: retrospective analysis.
Mueller-Lisse UG; Mueller-Lisse UL; Haller S; Schneede P; Scheidler JE; Schmeller N; Hofstetter AG; Reiser MF
J Comput Assist Tomogr; 2002; 26(3):432-7. PubMed ID: 12016375
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908
[TBL] [Abstract][Full Text] [Related]
32. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
[TBL] [Abstract][Full Text] [Related]
33. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
34. The Roles of ZnT1 and ZnT4 in Glucose-Stimulated Zinc Secretion in Prostate Epithelial Cells.
Lo ST; Parrott D; Jordan MVC; Joseph DB; Strand D; Lo UG; Lin H; Darehshouri A; Sherry AD
Mol Imaging Biol; 2021 Apr; 23(2):230-240. PubMed ID: 33140261
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
Cui Y; Han S; Liu M; Wu PY; Zhang W; Zhang J; Li C; Chen M
J Magn Reson Imaging; 2020 Aug; 52(2):552-564. PubMed ID: 32027071
[TBL] [Abstract][Full Text] [Related]
36. Exploring the diagnostic potential of adding T2 dependence in diffusion-weighted MR imaging of the prostate.
Syversen IF; Elschot M; Sandsmark E; Bertilsson H; Bathen TF; Goa PE
PLoS One; 2021; 16(5):e0252387. PubMed ID: 34043735
[TBL] [Abstract][Full Text] [Related]
37. Computed Tomography of the Prostate Gland in Healthy Intact Dogs and Dogs with Benign Prostatic Hyperplasia.
Pasikowska J; Hebel M; Niżański W; Nowak M
Reprod Domest Anim; 2015 Oct; 50(5):776-83. PubMed ID: 26303126
[TBL] [Abstract][Full Text] [Related]
38. MRI of Benign Prostatic Hyperplasia: Important Pre- and Posttherapeutic Considerations.
Han EA; Nandalur KR; Morgan MA; Arora SS; Loening AM; Bivalacqua TJ; Sundaram KM
Radiographics; 2023 May; 43(5):e220096. PubMed ID: 37022958
[TBL] [Abstract][Full Text] [Related]
39. Arterial spin labelling as a gadolinium-free alternative in the detection of prostate cancer.
Boschheidgen M; Schimmöller L; Kasprowski L; Abrar D; Arsov C; Albers P; Antoch G; Wittsack HJ; Ullrich T
Magn Reson Imaging; 2021 Jul; 80():33-38. PubMed ID: 33905833
[TBL] [Abstract][Full Text] [Related]
40. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report.
Narayan P; Jajodia P; Kurhanewicz J; Thomas A; MacDonald J; Hubesch B; Hedgcock M; Anderson CM; James TL; Tanagho EA
J Urol; 1991 Jul; 146(1):66-74. PubMed ID: 1711587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
